Amiodar
Amiodar is a medicine authorised by Swissmedic under authorisation number 55721. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 19 May 2004 and the authorisation is valid without a time limit. ATC code C01BD01 places the medicine in the group Cardiac therapy.
| Authorisation number | 55721 |
|---|---|
| Name | Amiodar |
| Full name | Amiodar, Tabletten |
| Authorisation holder | Sandoz Pharmaceuticals AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C01BD01 |
| First authorisation | 19 May 2004 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 2 | Amiodar, Tabletten | B | 19 May 2004 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 20 | Tablette(n) | C01BD01 | 02.02.0. | B |
| 4 | 60 | Tablette(n) | C01BD01 | 02.02.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Amiodar authorised in Switzerland?
Yes. Amiodar is authorised by Swissmedic under authorisation number 55721, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Amiodar have?
Amiodar is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Amiodar?
The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.